Company Filing History:
1 out of 74 
1 out of 7 
1 out of 10 Years Active: 2025
Title: The Innovative Contributions of Ernesto J Podestá
Introduction
Ernesto J Podestá is a notable inventor based in Ciudad Autónoma de Buenos Aires, Argentina. He has made significant contributions to the field of cancer research, particularly through his innovative patent related to tumor treatment.
Latest Patents
Podestá holds a patent for an Acyl-CoA synthetase 4 (ACSL4) inhibitory compound. This new compound, identified as formula A, is designed for the treatment of aggressive and/or resistant tumors that express acyl-CoA synthetase 4 and/or depend on steroid action. The compound has shown promise in inhibiting tumor growth in breast and prostate cancers that express ACSL4. Additionally, it inhibits steroid synthesis and sensitizes cancer cells to chemotherapeutic and hormone therapy agents. The patent also includes pharmaceutical compositions comprising the ACSL4-inhibitory compound and its combinations with other anticancer agents for therapeutic use.
Career Highlights
Throughout his career, Podestá has been associated with prominent research institutions, including the National Scientific and Technical Research Council (CONICET) and the National University of Quilmes. His work has focused on developing innovative solutions to combat cancer, showcasing his dedication to advancing medical science.
Collaborations
Podestá has collaborated with esteemed colleagues such as Paula M Maloberti and Ulises D Orlando. These partnerships have contributed to the success of his research and the development of his patent.
Conclusion
Ernesto J Podestá's contributions to cancer research through his innovative patent highlight his commitment to improving treatment options for patients. His work exemplifies the impact of dedicated inventors in the field of medical science.